Statements in which the resource exists as a subject.| Predicate | Object |
|---|
|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-2-25
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
X
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1551-8396
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
6-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11366250-Anti-HIV Agents,
pubmed-meshheading:11366250-Antiviral Agents,
pubmed-meshheading:11366250-Clinical Trials as Topic,
pubmed-meshheading:11366250-Dideoxynucleosides,
pubmed-meshheading:11366250-Drug Combinations,
pubmed-meshheading:11366250-Drug Hypersensitivity,
pubmed-meshheading:11366250-Drug Resistance, Microbial,
pubmed-meshheading:11366250-HIV Infections,
pubmed-meshheading:11366250-Hepatitis C,
pubmed-meshheading:11366250-Humans,
pubmed-meshheading:11366250-Ribavirin
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Product information.
|
|
pubmed:publicationType |
Newspaper Article
|
